Melinda McGrathChief Executive Officer and Executive Director Read More
Melinda McGrathChief Executive Officer and Executive Director
Ms Melinda McGrath has been the Chief Executive Officer and Executive Director of ACL since 2015. Melinda has more than 30 years’ experience in healthcare with over 20 years of experience in chief executive roles and over 13 years of experience in pathology CEO roles.
Melinda has played a lead role in the organisation’s transformation, building ACL’s scale and operational performance improvement over the past six years, overseeing the integration of Healthscope’s Australian pathology business, St John of God Health Care’s pathology business, Perth Pathology and SunDoctors. She has also driven the establishment of one performance oriented culture across the organisation, via one unified integrated pathology system.
Melinda was Chief Executive Officer of QML Pathology (part of Healius) from 2008 to 2015, where she developed five QML brands and established Tasmania Medical Laboratories. Prior to that, Melinda held various chief executive roles at private regional and tertiary referral hospitals in Queensland including The Sunshine Coast Private Hospital, St Andrew’s War Memorial Hospital and St Stephens Private Hospital.
Melinda has held board member positions at Metro North Hospitals and Health Service including Royal Brisbane, Prince Charles, Redcliffe, Caboolture and related health services, and a superannuation fund, UC Super.
Melinda holds a Bachelor of Human Movement Studies Degree and a Bachelor of Arts Degree from the University of Queensland, a Master of Business Administration from the University of Central Queensland, and a Certificate in Governance Practice from the Governance Institute of Australia.
James DavisonChief Financial Officer Read More
James DavisonChief Financial Officer
Mr James Davison joined Healthscope Limited (precursor to ACL) in 2011 and has been the Chief Financial Officer since 2015. James is responsible for the financial functions of ACL and has over 20 years of experience in the healthcare industry.
James has comprehensive experience across financial management, planning, reporting and governance. James also has significant experience in pathology acquisitions, divestments, restructures, operational efficiency improvements and cost-out programs.
Prior to joining ACL, James held executive finance roles as General Manager Finance Pathology of Australia and International at Healthscope, Chief Financial Officer at Australia Diagnostics Group and General Manager Finance at Mayne/Symbion Health Limited and Primary Healthcare/Healius Limited.
James has an in-depth knowledge of pathology in international markets including Singapore, Malaysia and New Zealand.
James holds a Bachelor of Business Degree from Swinburne University of Technology and is a Certified Practicing Accountant.
Associate Professor Tony LandgrenNational Medical Director and Chief Pathologist Read More
Associate Professor Tony LandgrenNational Medical Director and Chief Pathologist
Associate Professor Tony Landgren joined ACL in 2009 as the National Medical Director and Chief Pathologist. He is the Designated Person under the terms of ACL’s accreditation with NATA and has executive responsibility for clinical governance, risk management, patient safety and regulatory compliance.
Prior to joining ACL, Tony has worked as a pathologist, medical administrator and commercial lawyer in private, public and academic practice in Queensland, New South Wales, Victoria and the United States.
Tony is the current Chair of The Board of Royal College of Pathologists of Australasia Quality Assurance Programs Pty Ltd and Director of the Department of Anatomical Pathology at the Royal Melbourne Hospital. He holds academic positions at the University of Melbourne. He was for 12 years the Chair of the Board of Education and Assessment and a Director of the Royal College of Pathologists of Australasia.
Tony graduated in Medicine and Law from the University of Melbourne then trained in anatomical and forensic pathology in Victoria. He is a fellow of the Royal College of Pathologists of Australasia, the Australasian College of Legal Medicine and is a member of the Royal Australian College of Medical Administrators. He is also a Barrister and Solicitor of the Supreme Court of Victoria specialising in biotechnology and health law.
Anthony FriedliChief Operating Officer & Victoria CEO Read More
Anthony FriedliChief Operating Officer & Victoria CEO
Mr Anthony Friedli joined ACL in 2016 and is the Chief Operating Officer and Chief Executive Officer of Victoria.
Anthony’s responsibilities include leading the business transformation on a national basis and managing the Victorian operation. Anthony also oversees the human resources, quality and risk and business improvement functions across ACL.
Anthony has over 20 years of experience in business transformation and over seven years of experience in pathology.
Prior to joining ACL, Anthony was the Managing Director of Australia and New Zealand for Kepner-Tregoe, a management consulting company specialising in business transformation. Anthony has also held management roles within the telecommunications, banking and manufacturing industries where he led transformation programs.
Anthony holds a Bachelor of Engineering Degree from University of Technology Sydney and a Master of Business Administration (Finance/Strategy) from Macquarie Graduate School of Management. Anthony is a certified Six Sigma Master Blackbelt and qualified project manager.
Sean JacksonChief Information Officer Read More
Sean JacksonChief Information Officer
Mr Sean Jackson joined Healthscope Limited (precursor to ACL) in 2011 and has been the Chief Information Officer since 2015.
Sean has more than 20 years of information related experience in the pathology industry that includes management, operations and application development.
Sean has led transformation projects spanning multiple IT disciplines, including the provision of technology systems for start-up labs, team transformation, major relocations, stand-up of disaster recovery systems, laboratory information system implementations, upgrades and laboratory acquisitions and divestments.
Prior to joining ACL, Sean was the Pathology IT Manager of Australia and International at Healthscope, Chief Information Officer at Australian Diagnostics Group and National Software Development Manager (Pathology) at Healius Limited. Sean commenced his career as a Programmer and Network Administrator at Barratt and Smith Pathology.
Prior to commencing in the field of information technology, Sean studied Biotechnology at the University of Technology Sydney.
Joe GeranNational Marketing Director Read More
Joe GeranNational Marketing Director
Mr Joe Geran joined ACL in 2015 and is the National Marketing Director. Joe is responsible for marketing strategy and managing ACL’s brand portfolio.
Joe has over 20 years of experience in healthcare including over 17 years of experience in pathology. Joe’s former roles include National Sales and Marketing Executive for SDS Pathology and Marketing Manager and Metro Business Manager for QML Pathology.
Prior to joining ACL, Joe held senior positions at Healius Limited, and has previously worked for BUPA and International SOS.
Joe’s focuses include revenue maximisation, strategy development, chronic disease management and the integration of technology in general practice leveraging a deep understanding of ordering patterns of referrers and Medicare funding.
Joe holds a Bachelor of Nursing Degree from Griffith University.
Chris BrownlowNew South Wales and Australian Capital Territory CEO Read More
Chris BrownlowNew South Wales and Australian Capital Territory CEO
Mr Chris Brownlow has been the Chief Executive Officer of New South Wales and ACT since joining ACL in 2011.
Chris has 20 years of healthcare experience which includes experience in medical laboratories since 2002. Chris has held executive and senior management roles at Healthscope Limited, Healius Limited, Symbion Health Limited and Mayne Health.
Chris has been a Board member of National Association of Testing Authorities and is currently a Board member and Treasurer of Australian Pathology, the national peak body for private pathology in Australia.
Chris’ focuses include strategy development and execution, leadership and change management. Chris has been involved in and led a number of transformation projects including the design, accreditation and commissioning of new laboratories as well as major relocations, laboratory acquisitions, divestments and mergers.
Chris holds a Bachelor of Business Degree from the University of Technology Sydney and is a member of the Australian Institute of Company Directors.
Shae SeymourWestern Australia CEO Read More
Shae SeymourWestern Australia CEO
Ms Shae Seymour joined ACL as Chief Executive Officer of Western Australia in 2018 to lead the Western Australian business through its’ integration and operational change within ACL.
Shae has over 15 years’ experience in health care and hospital management and has held executive and senior management roles within the Department of Health as well as various commercial, contract and finance roles in the private sector. Prior to joining ACL, Shae was the Executive Director of the Armadale Kalamunda Hospital Group.
Shae’s key interests include clinical and corporate governance, leadership and culture development, strategy execution and change management. Shae has advised on and lead state wide health reform initiatives as well as being involved in a number of transformation projects including emergency department reform across Western Australia and the commissioning of the Fiona Stanley Hospital.
Shae holds Bachelor of Commerce, Bachelor of Science (Physiotherapy) and Bachelor of Social Science Degree’s from Curtin University. Shae also completed the Harvard Business School Executive Program “Leading Health Care Delivery” in 2018 and is a member of the Australian Institute of Company Directors.
Eric SwaynSouth Australian and Northern Territory CEO Read More
Eric SwaynSouth Australian and Northern Territory CEO
Mr Eric Swayn joined ACL in 1999 and has been the Chief Executive Officer of South Australia and Northern Territory since 2015.
Eric has over 20 years of experience in pathology, and has held various scientific and leadership roles across a number of metropolitan and regional community and hospital laboratories. Eric is a current Director of the National Association of Testing Authorities.
Eric led the design and commissioning of the new Adelaide Airport central laboratory in 2018, and previously managed the successful consolidation of three Queensland laboratories into one state-of-the-art central laboratory for Healthscope.
Eric’s current role includes National Procurement Manager. During 2020, he was instrumental in setting up COVID-19 testing platforms in each of the central laboratories across Australia. His former roles include State Manager for Healthscope Pathology in Queensland, South Australia and Northern Territory, as well as managing a number of regional laboratories both within hospital and community settings.
Eric holds a Bachelor of Applied Science Degree and a Graduate Certificate in Business Administration from the University of South Australia.